{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T09:09:47Z","timestamp":1778404187782,"version":"3.51.4"},"reference-count":35,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:00:00Z","timestamp":1235001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Interleukin\u20108 (IL\u20108) has been shown previously to associate with different individual clinical manifestations and activity of Behcet's disease (BD), but its association with vascular involvement has not been established.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Forty\u2010five untreated patients with BD and 29 healthy individuals were included in the study. The activity of patients was based on the existence of two or more symptoms and a statistically significantly high Behcet's Disease Activity Index (BDAI) at the time of the study. IL\u20108, erythrocyte sedimentation rate (ESR), and C\u2010reactive protein (CRP) results were evaluated with respect to activity, vascular involvement, and other specific individual clinical manifestations of the disease.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> IL\u20108 levels were found to be significantly elevated in active BD compared with inactive BD (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.006) and healthy controls (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.000), with median values of 267 (53\u20132000), 137 (52\u2013290), and 58\u00a0pg\/mL (53\u2013160\u00a0pg\/mL), respectively. Unlike ESR and CRP, IL\u20108 levels showed a high correlation with BDAI scores (<jats:italic>r<\/jats:italic>\u00a0=\u00a00.743, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.00) and the number of active clinical manifestations (<jats:italic>r<\/jats:italic>\u00a0=\u00a00.646, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.00). Serum levels of IL\u20108 were increased in patients with oral ulcers, genital ulcers, eye lesions, and vascular lesions, with median values and significance levels of 254.5 (53\u20132000), <jats:italic>P<\/jats:italic>\u00a0=\u00a00.05; 254.5 (52\u20131400), <jats:italic>P<\/jats:italic>\u00a0=\u00a00.03; 254.5 (72\u20132000), <jats:italic>P<\/jats:italic>\u00a0=\u00a00.029; and 593\u00a0pg\/mL (110\u20132000\u00a0pg\/mL), <jats:italic>P<\/jats:italic>\u00a0=\u00a00.001, respectively. In addition, IL\u20108 levels in the active patient group with vascular involvement were significantly higher than the levels in those without vascular involvement.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Serum IL\u20108 levels are increased in the active phase of BD. This marker may be useful in the early detection of vascular involvement.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2009.03905.x","type":"journal-article","created":{"date-parts":[[2009,2,20]],"date-time":"2009-02-20T02:24:08Z","timestamp":1235096648000},"page":"259-264","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Significance of serum interleukin\u20108 levels in patients with Behcet's disease: high levels may indicate vascular involvement"],"prefix":"10.1111","volume":"48","author":[{"given":"Selda Pelin","family":"Kartal Durmazlar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gul Bahar","family":"Ulkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Eskioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semih","family":"Tatlican","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Mert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Akgul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,2,19]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"1152","article-title":"\u00dcber rezidivierende, apht\u00f6se, durch ein virus verursachte Geshw\u00fcre am Mund am Auge und an den Genitalien","volume":"105","author":"Behcet H.","year":"1937","journal-title":"Dermatol Wochenschr"},{"key":"e_1_2_7_3_2","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease","volume":"335","author":"International Study Group for Behcet's disease","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02912462"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/ejvs.2000.1240"},{"key":"e_1_2_7_6_2","first-page":"402","article-title":"Vascular involvement in Behcet's disease","volume":"19","author":"Koc Y","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/35.2.139"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.1.48"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2003.11.040"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0344-0338(88)80135-3"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(98)80001-2"},{"key":"e_1_2_7_12_2","first-page":"1544","article-title":"Over production of monocyte derived tumor necrosis factor alpha, interleukin IL\u20106, IL\u20108 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mege JL","year":"1993","journal-title":"J Rheumatol"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1994.tb01762.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.54.7.610"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1076\/ocii.12.1.53.28062"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-003-0668-y"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-003-0851-x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/09629350220131935"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02184.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000068888"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.8.728"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg453"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.675"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004030000128"},{"key":"e_1_2_7_25_2","first-page":"249","article-title":"IL\u20108 producing cells in patients with Behcet's disease","volume":"18","author":"Mantas C","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2000.00859.x"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2005.04.009"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.2.128"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.1999.40.2.152"},{"key":"e_1_2_7_30_2","first-page":"321","article-title":"Cytokines in Behcet's disease","volume":"23","author":"Say\u0131nalp N","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018426"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.278.22.2008"},{"key":"e_1_2_7_33_2","first-page":"721","article-title":"Effects of colchicines on inflammatory cytokines and selectins in familial Mediterranean fever","volume":"16","author":"Kiraz S","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_34_2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1055\/s-0038-1650405","article-title":"Circulating thrombomodulin as a clue of endothelial damage in Behcet's disease","volume":"75","author":"Haznedaroglu IC","year":"1996","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1996.396853000.x"},{"key":"e_1_2_7_36_2","first-page":"261","article-title":"Behcet's disease","volume":"23","author":"Arca E","year":"2003","journal-title":"Turk Klin J Med Sci"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2009.03905.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2009.03905.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T16:23:52Z","timestamp":1696955032000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2009.03905.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,19]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1365-4632.2009.03905.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2009.03905.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,19]]},"assertion":[{"value":"2009-02-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}